Why is Tilray stock down 4.5% today?

Traders Union
All News
Stocks
Tilray slides 4.53% today to $3.38

Highlights

Tilray posted record first-quarter fiscal 2027 net revenue of $257.1 million, with beverage revenue up 82% after acquiring BrewDog.
The company reported a net loss of $40 million as cannabis revenue fell 13% to $56.1 million and international cannabis sales increased 21%.
Shares of Tilray trade below key moving averages, with strong negative momentum and a projected 5-day range of $3.16 to $3.6.

Beverage segment growth offset by net loss and cannabis weakness

Tilray reported record first-quarter fiscal 2027 net revenue of $257.1 million, driven by an 82% increase in beverage segment revenue following the BrewDog acquisition. The company posted a net loss of $40 million for the quarter, compared to net income of $1.5 million in the previous year. Cannabis revenue declined 13% year-over-year to $56.1 million, while international cannabis sales rose 21% and adjusted EBITDA guidance was reaffirmed, though price action has remained under broader selling pressure.

Anton Kharitonov, expert at Traders Union, sees Tilray Brands Inc under heavy bearish pressure following disappointing earnings and a sharp net loss. He highlights that revenue growth was driven mostly by acquisitions, masking the core weakness in cannabis revenues. Technical signals confirm a negative trend, with all major averages acting as resistance and momentum indicators remaining red. Kharitonov warns that oversold readings do not guarantee a reversal under persistent macro and sector headwinds. "Strong caution is warranted — until $3.39 is convincingly reclaimed, downside risk dominates any upside hopes for Tilray."

Viktoras Karapetjanc, expert at Traders Union, believes Tilray is navigating a challenging but opportunity-rich phase. He notes that the record $257.1 million revenue and international cannabis sales growth signal strategic momentum, despite headline losses. The beverage segment's performance and reaffirmed EBITDA guidance lay groundwork for future strength. Karapetjanc states, "Near-term volatility aside, the bullish structure remains promising once the stock stabilizes above $3.39 — patient investors can find setups for longer-term growth."

Parshwa Turakhiya, analyst, sees sentiment turning decisively negative with persistent selling and technical misalignment. He observes short-term opportunities for volatility-based trades as the price compresses between $3.16 and $3.6. The analyst points out that oversold indicators could trigger a quick relief bounce, but only above $3.39 do bulls gain real momentum. "For now, I suggest traders watch the $3.35 support closely — nimble positioning is key until a clear break emerges."

Bearish signals persist as all-timeframe momentum aligns negative

Tilray remains below its 20-day, 50-day, and 200-day moving averages at $3.89, $4.29, and $5.96, underscoring ongoing pressure across all timeframes. The near-term resistance sits at $3.39, while support is established at $3.35, and both the moving averages and Ichimoku Kijun at $4.02 confirm the prevailing bearish trend. Momentum indicators such as MACD and Bull/Bear Power are negative, and the ADX signals a weak trend. RSI, Stochastic RSI, and CCI all point to an oversold condition, while the Awesome Oscillator remains neutral. The stock closed near its session low, with intraday volatility at 5.97%, indicating intense selling pressure through the day.

Previously it was reported that Tilray faced ongoing technical weakness and elevated downside risk, with losses in its core cannabis segment offset only partially by growth in beverages. The latest results reinforce this negative outlook, and traders should monitor the $3.35 support zone closely, as a sustained break below this level could prompt further downside towards the $3.16 range in the near term.

Source of Data: TLRY Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.